Gunia S, Liebe D, Koch S
Department of Pathology, HELIOS Klinikum Bad Saarow, Charité-University Medicine Teaching Hospital, Bad Saarow, Germany.
J Clin Pathol. 2008 Jun;61(6):707-12. doi: 10.1136/jcp.2008.055954.
To evaluate selected markers in terms of their possible relation to the development of recurrence in microsurgically resected sinonasal inverted papilloma (SIP) in order to advance understanding of the mechanisms pathogenetically involved, and to identify novel biomarkers for individual risk assessment in SIP.
Retrospective computerised database analysis and thorough review of medical charts was performed in order to identify all patients with newly diagnosed SIP who underwent microinvasive endonasal surgery at the HELIOS Klinikum Bad Saarow and at the Klinikum Hoyerswerda (Germany) between 1985 and 2005, yielding a total of 73 patients with newly diagnosed SIP. Among these, 22 patients (30.1%) developed recurrence during follow-up. Recurrent SIP were also microsurgically resected. Therefore, archival paraffin-wax-embedded tissues comprising a total of 95 SIP were immunostained for a panel of selected antigens (Ki67/CK5/CK14/E-cadherin/CD56) functionally involved in cellular adhesion structures or in proliferative activity. Adjacent non-papillomatous sinonasal mucosa was available in all cases and served as normal controls.
Increased proliferative activity (Ki67) and loss of basal cell keratin 14 (CK14) expression were related to the development of recurrence in microsurgically resected SIP.
These findings might advance understanding of the pathogenesis behind the development of recurrence in microsurgically resected SIP by focusing on so far neglected alterations of cell-matrix connections at the epithelial-stromal interface in SIP, and might hint at CK14 representing a possible novel biomarker for individual risk assessment in microsurgically resected SIP.
评估某些标志物与经显微手术切除的鼻窦内翻性乳头状瘤(SIP)复发可能的相关性,以增进对其发病机制的理解,并识别用于SIP个体风险评估的新型生物标志物。
进行回顾性计算机数据库分析并全面查阅病历,以识别1985年至2005年间在德国巴特萨罗夫市HELIOS Klinikum医院和霍耶斯韦达市Klinikum医院接受鼻内镜微创手术的所有新诊断SIP患者,共获得73例新诊断的SIP患者。其中,22例患者(30.1%)在随访期间出现复发。复发性SIP也接受了显微手术切除。因此,对总共95例SIP的存档石蜡包埋组织进行免疫染色,检测一组在细胞黏附结构或增殖活性中起作用的选定抗原(Ki67/细胞角蛋白5/细胞角蛋白14/E-钙黏蛋白/CD56)。所有病例均有相邻的非乳头状鼻窦黏膜作为正常对照。
增殖活性增加(Ki67)和基底细胞角蛋白14(CK14)表达缺失与经显微手术切除的SIP复发相关。
这些发现可能通过关注SIP上皮-基质界面迄今为止被忽视的细胞-基质连接改变,增进对经显微手术切除的SIP复发发病机制的理解,并可能提示CK14代表经显微手术切除的SIP个体风险评估的一种可能的新型生物标志物。